Inside the $4B AskBio deal, the third largest buyout ever for an NC bioscience firm Date Published: October 27, 2020 RESEARCH TRIANGLE PARK – Asklepios BioPharmaceutical (AskBio), a pioneering gene therapy company born in Chapel Hill 19 years ago and…
Raleigh ag biotech startup led by Black cofounder & CEO pivots to fight pandemic Date Published: October 27, 2020 RESEARCH TRIANGLE PARK – In the early days of the COVID-19 pandemic, there were shortages of many critical resources, from…
Brain breakthrough? Duke scientists help create first living, bioprinted aneurysm outside of human body Date Published: October 26, 2020 DURHAM – Brain aneurysms affect about one in every 50 Americans and can lead to serious medical emergencies, including stroke,…
Durham startup Tellus moves closer to OK for neonatal brain treatment Date Published: October 23, 2020 DURHAM – Tellus Therapeutics is getting closer to approval for its neonatal brain injury treatment. This week, the Durham-based biotech…
Now hear this: Durham’s MED-EL Medical Electronics wins Innovator award Date Published: October 23, 2020 RESEARCH TRIANGLE PARK – MED-EL Medical Electronics, a hearing-technology company with U.S. headquarters in Durham, was recently named “Innovator of…
Gene editing shows promise as tool to fight neuro disorder in babies, UNC study finds Date Published: October 23, 2020 CHAPEL HILL – Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe…
‘A major pest:’ NCSU researcher helps unravel genetic blueprint of a bug ‘that’s on everything’ Date Published: October 21, 2020 RALEIGH – The western flower thrips — an invasive insect that’s not much bigger than a pinhead — takes a…
IQVIA’s CEO: Life science giant ‘delivering results above our financial targets’ Date Published: October 20, 2020 DURHAM – IQVIA Holdings Inc. (IQV) on Tuesday reported third-quarter profit of $101 million. The Durham, North Carolina-based company said…
Hatteras, one of the Triangle’s most important biotech investors, raises more than $137M Date Published: October 16, 2020 Hatteras Venture Partners, one of the Triangle’s most important biotechnology investors, has raised more $137 million for its newest fund,…